SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending as investors digest news of warrant distributions to shareholders, a move perceived by some as a strategic alignment of management incentives while others fear potential dilution. Community members are debating the implications of these warrants, particularly how they might impact the stock's price and future partnerships, especially a speculated collaboration with Robinhood ($HOOD). The broader discussion revolves around Opendoor's long-term vision, its shift towards becoming a technology-driven marketplace for real estate, and its ability to navigate a challenging housing market.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is active following shareholder approval of Elon Musk's compensation package, sparking debate about the company's future and Musk's role. Community discussions revolve around ambitious targets tied to the package, including market cap growth and robotaxi deployment. Some traders anticipate increased volatility and a potential short squeeze, while others express skepticism about the company's valuation and long-term prospects.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation ($ACHR) is trending amid discussions around a recent capital raise and the acquisition of Hawthorne Airport, sparking debates about dilution and strategic implications. Community members are weighing the potential benefits of the airport acquisition against concerns over cash burn and management decisions. Speculation about partnerships, particularly with Tesla, and upcoming earnings are also fueling active discussions.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending amid a new partnership with ESPN and anticipation for upcoming earnings, though some express concerns about increased spending and competition from prediction markets. Community discussions revolve around the deal's potential impact, the company's profitability, and whether it can maintain its market position. Some investors are optimistic about long-term growth, while others cite recent disappointing results and a challenging economic climate.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SOUN is trending as investors discuss the company's recent earnings report and future profitability, with community members highlighting a beat on expectations and a raised full-year outlook. Despite positive results, the stock's price action is generating mixed sentiment, as some express concerns about broader market conditions and potential government shutdowns impacting performance. Optimistic investors focus on SoundHound's AI technology, partnerships, and long-term growth potential in the rapidly expanding AI sector.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending following its Q3 2025 earnings report, which highlighted significant revenue growth and positive margins, alongside a mention of continued progress in their relationship with Amazon. The community is dissecting the earnings call for insights on future prospects, particularly regarding potential Amazon partnerships and government/army deals. Bullish sentiment revolves around the company's growth trajectory, zero debt, and potential for significant returns in the coming years, while some are wary of broader market conditions impacting the stock.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTD is trending amid discussions around its recent earnings and their implications, with community members debating the company's performance and future outlook. There is active discussion about Amazon's competitive presence in the ad tech space, as well as whether TTD can capitalize on growth opportunities, particularly in CTV. Despite some positive sentiment, concerns persist regarding the company's long-term performance.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors grapple with the stock's recent sharp decline and speculate on potential catalysts. Community discussions revolve around the upcoming earnings report and the impact of U.S.-China trade relations on the rare earth market, with some highlighting long-term growth potential amid concerns about near-term volatility and Chinese competition.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is trending amid discussions about its earnings report and a significant drop in stock price, despite strong revenue growth; the community is focused on understanding the impact of a one-time distributor termination cost and its relationship with Pepsi. Some traders see this dip as a buying opportunity, while others express concerns about management and potential market manipulation, comparing it to competitor Monster Energy's performance.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer ($PFE) is trending amid a bidding war with Novo Nordisk ($NVO) for Metsera, an obesity drug developer, with the community debating the strategic value and potential overpayment. Discussions also revolve around Pfizer's upcoming earnings, dividend payouts, and the implications of a lawsuit filed against Metsera and Novo Nordisk. Some traders express frustration with the stock's price action and discuss options strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates

Progyny (PGNY) delivered earnings and revenue surprises of +15.38% and +4.19%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Are Investors Undervaluing Progyny (PGNY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Shares of Progyny logged their best session in two months on Thursday after BofA Securities reiterated a ‘Buy’ rating and $30 price target, calling the forthcoming White House initiative to expand access to in-vitro fertilization (IVF) an “incremental positive” for the company.<a href="https://stocktwits.com/symbol/PGNY">Progyny’s stock</a> surged 5% to close at $21.33 on Thursday, marking their highest levels in over a month, before slipping 0.7% in after-hours trading.BofA Securities’ TakeBofA Securities said the actual impact may be “more nuanced.” The firm said the spotlight around IVF is a positive for awareness and may drive some demand for coverage in certain pockets of employers.&nbsp;Given Progyny is a “market leader” with broad geographic coverage, BofA Securities said the company appears well-positioned to capture upside if there is, in fact, a benefit to coverage and utilization.Policy BackdropU.S. President Donald Trump is set to unveil measures to expand IVF access. Earlier Thursday, the administration announced a deal with Merck KGaA under which its U.S. arm EMD Serono will sell fertility drugs Gonal-f, Ovidrel, and Cetrotide directly to consumers, with a combined 84% discount when all three are used in an IVF cycle, alongside tariff relief arrangements, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/healthcare-pharmaceuticals/white-house-set-announce-proposal-seeking-make-ivf-more-accessible-nyt-reports-2025-10-16/">report</a>.Trump also outlined plans to make it legal for companies to offer supplemental insurance for fertility care and to issue guidance encouraging employer IVF coverage, with estimated savings of $2,200 per cycle. IVF typically costs $12,000–$25,000 per cycle in the U.S.Stocktwits Traders Turn Bullish On Progyny After IVF NewsOn Stocktwits, retail sentiment for Progyny was ‘extremely bullish’ amid ‘extremely high’ message volume.<figure class="image"><img style="aspect-ratio:967/127;" src="https://news.stocktwits-cdn.com/pgny_st_meter_jpg_a5b3ccbd69.webp" alt="pgny st meter.jpg" width="967" height="127"><figcaption>PGNY sentiment and message volume as of October 16 | Source: Stocktwits</figcaption></figure>One retail trader predicted Progyny’s after-hours surge on Thursday in advance and said it will also move higher into the next trading day, urging others to buy before it’s “too late.”&nbsp;<stembedurl>https://stocktwits.com/JrNannies/message/632648094</stembedurl>Another user noted that Progyny is directly linked to news on carve-outs and supplemental insurance, unlike other IVF-related stocks that&nbsp;rallied simply on name association.<stembedurl>https://stocktwits.com/thegreatone/message/632647572</stembedurl>Progyny’s stock has risen 24% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Progyny’s stock (PGNY) has risen 24% so far in 2025. (Photo credit: Getty Images)

Progyny Stock Logs Best Day In 2 Months As BofA Calls Trump IVF Policy ‘Incremental Positive’ — Traders Eye More Upside

Trump may potentially announce new measures to expand access to in-vitro fertilization, including guidance for employers to offer supplemental fertility insurance and steep discounts on key IVF drugs.

Equity

Is Progyny (PGNY) Stock Undervalued Right Now?

Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates

Progyny (PGNY) delivered earnings and revenue surprises of +9.09% and +3.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -127.27% and -4.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates

BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of +15.79% and +5.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Progyny (PGNY) Earnings Expected to Grow: Should You Buy?

Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Progyny Inc

$HOOD

$ELF

$DUOL

$CELH

Which of these post-earnings decliners are you most interested in buying?

Current Price	$18.01
Prev Close	$18.88
Open	$18.80
Dividend Yield	0.00%
50-Day Moving Average	$20.93
Beta	0.67
Avg. Volume	1.63M
PE Ratio	30.58

52-Week High	$26.76
52-Week Low	$13.39
Market Capitalization	$1.55B
EPS (Annual)	$0.5693
Price to Book	3.00
Revenue Per Employee	$1.72M
Enterprise Value/EBITDA	N/A

PGNY
Progyny Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PGNY News

PGNYProgyny Inc